Furthermore, an inhibitor of NFκB signaling, BAY 11-7082, reversed the effects of both CON and SCA platelets on the induction of ICAM-1 expression by HUVEC and inhibited the E-selection expression induced by SCA platelets. This evidence concerns the gene NFKB1 and autosomal dominant cerebellar ataxia.